Xeriant, Inc.
XERI· OTC
XERIXeriant, Inc.
Filed Nov 22, 2021 · 10-Q · 53 days after period end · 0001477932-21-008723
| Metric | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Net Income | -$4.45M | -$327.07K | -$19.17K | -$134.18K |
| EPS Diluted | -$0.02 | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Xeriant, Inc. · CIK 1481504 · Engraved from SEC EDGAR
ended Sep 30, 2021 · filed Nov 22, 2021 · 53 d after period end
